Tag: Vaccines
Confidence in Vaccines Both Steady and Rising in U.S. Adults
Increases seen in acceptance for new respiratory syncytial virus vaccines
Influenza Vaccine Effective Against Severe Illness in Children
Vaccine effectiveness of 52.8 percent seen for ED visits, 52.3 percent for noncritical hospitalization, 50.4 percent for critical hospitalization
RSVpreF Vaccine Effective in Preventing Severe RSV in Older Adults
Vaccine effectiveness 91 percent using strict controls in a population of adults aged 60 years or older
ACIP Updates Recommendations for Bexsero MenB-4C Vaccine
ACIP recommends extending interval for two-dose series and adding three-dose series in accordance with FDA label
Concerns Raised as Too Few U.S. Children Have Received Flu Vaccine
CDC continues to recommend that everyone aged 6 months and older get a flu shot every year
Trump Says RFK Jr. Free to Revisit Discredited Autism/Vaccine Link
Vaccination of 27- to 45-Year-Olds Against HPV Is Less Cost-Effective
Vaccination of 'mid-adults,' including those at higher risk, results in higher number needed to vaccinate than that seen for younger people
COVID-19, Flu, RSV Vaccine Coverage Low for Nursing Home Residents
As of Nov. 10, 2024, 29.7 percent of nursing home residents had received a 2024 to 2025 COVID-19 vaccine
COVID-19, Flu, RSV Vaccine Coverage Low for Adults in 2024 to 2025 Season
34.7 percent of adults reported having received influenza vaccine; 17.9 percent received COVID-19 vaccine
Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in Infants
Seasonal maternal RSV vaccination may be cost-effective, as well as nirsevimab, particularly for those with higher risks
